- Home
- / 024 Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
024 Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$3.5
2021-01-28
Market Capitalization
$295.7 K
2021-01-28
Revenue
$1.1 M
FY, 2016
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2016 |
|---|---|---|
| Revenue | 266.3K | 1.1M |
| Cost of goods sold | 63.8K | 174.4K |
| Gross profit | 202.6K | 905.1K |
| Gross profit margin, % | 76.1% | 83.8% |
| General and administrative expense | 655.7K | 719.0 |
| Operating expense total | 675.3K | 43.2K |
| EBIT | (472.7K) | |
| EBIT margin, % | -177.5% | |
| Interest income | 3.5K | |
| Interest expense | 18.8K | 308.0 |
| Pre tax profit | (131.3K) | 621.0K |
| Net Income | (131.3K) | 621.0K |